Product Images Rosuvastatin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Rosuvastatin NDC 71610-798 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 71610 0798 15
Aphena - Aphena
Figure-01 - figure 1
This description provides data on the effectiveness of a treatment compared to a placebo. The treatment group had 8901 participants at the start, decreasing over the years to 8412, 3892, 1352, 543, and 156 individuals. In contrast, the placebo group started with 8901 individuals and decreased to 8353, 3872, 1333, 534, and 173 participants over the same period. The treatment showed a statistically significant difference with a hazard ratio of 0.56 (95% CI 0.46-0.69) and a p-value of less than 0.001. The data also includes the number at risk over the years for both groups.*
Figure-02 - figure 2
This is a statistical analysis comparing the effectiveness of Rosuvastatin 20mg versus Placebo 20mg in preventing cardiovascular events. The study involved 8901 participants and evaluated various endpoints such as Cardiovascular Death, Nonfatal Stroke, Nonfatal MI, Hospitalized unstable Angina, and Arterial revascularization. Results show significant differences in event rates between the two groups, with Rosuvastatin demonstrating lower hazard ratios for most outcomes compared to the placebo.*
Figure-02 - figure 3
structural formula - rosuvastatin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.